Sid: No, not really confusing anything, as far as I can tell. The dividend shares that we have (from some of the posts, it sounds as though both dividend lots are restricted now, but I cannot tell for sure) are restricted. There is nothing I have read or heard (and happy to be corrected, if I am wrong), that indicates we will be able to trade dividend shares when the company [officially] IPOs [on NASDAQ]. IF that is the case, and all dividend shares are, in fact, Class A shares, they will remain restricted until 9-18 mos post-IPO. As for the Class A shares that already are trading OTC pink, sure, those can be bought [and sold] not only currently, but at anytime, IPO or no IPO. For those of us who have the dividend shares, however, and not buying them on the OTC market, those shares will have no value (i.e., cannot be traded for a gain) until the OTC converts, unless for some reason they become unrestricted - and no one has mentioned that happening before post-IPO. Based on the SEC filing, the dividend shares must, by definition, be Class A shares. Perhaps that is my error, i.e., assuming that those shares will remain restricted until after the IPO, and specifically 9-18 months after the IPO, when they convert. Has there been any communication from the company announcing a time frame that the dividend shares will become unrestricted?
By the way, thank you for responding. I guess posters like buildit never remove their rose-colored glasses, and anyone who does something other than bottom-line praise are condemned. E.g., I ask MMPJOE to explain, on behalf of the company for which he is the CEO/President, who submitted the required documentation to FINRA to have NUGX traded, and who confirmed the information in those submissions for FINRA. For that, I have received snarky responses at best. MMPJOE in particular sent me a private reply and called me a "pos." In the meantime, no substantive response.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links